|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismVPREB1 antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with NEVIS BRANDS, INC. /US/
0 Patents (Medical) associated with NEVIS BRANDS, INC. /US/
100 Deals associated with NEVIS BRANDS, INC. /US/
100 Translational Medicine associated with NEVIS BRANDS, INC. /US/